Evidence map›Paper›PMID 30669552›Full record

ReviewInternational journal of molecular sciences2019

Structure and Mechanism of the Divalent Anion/Na⁺ Symporter.

Min Lu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Cryo-EM structures reveal the HLife science alliance · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Why Nature Chose Potassium.Journal of molecular evolution · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Min LuDepartment of Biochemistry and Molecular Biology, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA. min.lu@rosalindfranklin.edu.
Rosalind Franklin University of Medicine and Science · US

Funding

Structural mechanisms of multidrug extrusion by the MATE antiportersR01GM094195 · NIGMS · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI LU, MIN · 2010 to 2018
$2.7M
NIGMS NIH HHS R01 GM094195NIGMS NIH HHS R01-GM094195
6 · The paper itself

Abstract

Integral membrane proteins of the divalent anion/Na⁺ symporter (DASS) family are conserved from bacteria to humans. DASS proteins typically mediate the coupled uptake of Na⁺ ions and dicarboxylate, tricarboxylate, or sulfate. Since the substrates for DASS include key intermediates and regulators of energy metabolism, alterations of DASS function profoundly affect fat storage, energy expenditure and life span. Furthermore, loss-of-function mutations in a human DASS have been associated with neonatal epileptic encephalopathy. More recently, human DASS has also been implicated in the development of liver cancers. Therefore, human DASS proteins are potentially promising pharmacological targets for battling obesity, diabetes, kidney stone, fatty liver, as well as other metabolic and neurological disorders. Despite its clinical relevance, the mechanism by which DASS proteins recognize and transport anionic substrates remains unclear. Recently, the crystal structures of a bacterial DASS and its humanized variant have been published. This article reviews the mechanistic implications of these structures and suggests future work to better understand how the function of DASS can be modulated for potential therapeutic benefit.

Indexed as

Amino Acid SequenceAnimalsAnionsBinding SitesBiological TransportHumansProtein BindingProtein ConformationProtein MultimerizationSodiumStructure-Activity RelationshipSymportersAnionsSodiumSymportersanion transporterdicarboxylate transportermembrane proteinsodium coordinationsodium symportersubstrate recognition

Identifiers

PMID30669552
PMCPMC6359215
OpenAlexW2908882141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.